Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdimFlu-W (H5N1) in Healthy Adults
NCT01640691Phase 2Completed
- Sponsor
- Adimmune
- Start
- Jul 2012
- Primary completion
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of AdimFlu-W in Influenza A H5N1 (H5N1), sponsored by Adimmune. Primary endpoints: Hemagglutination Inhibition Titer at Day 43 and Microneutralization Titer at Day 43. Started Jul 2012; status: completed.
02
Drugs
AdimFlu-W
03
Conditions
Influenza A H5N1 (H5N1)
Beyond the preview
Go deeper on NCT01640691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640691.